Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 4 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vomiting 3Postoperative Nausea and Vomiting 1Ovarian Neoplasms 1Neoplasms 1Myofibroma 1Adenomyosis 1

Interventions

Dexamethasone 23Ondansetron 12Palonosetron 11Aprepitant 9Granisetron 7Olanzapine 5ramosetron 3netupitant, palosentron drug combination 3casopitant 3Radiotherapy 3fosaprepitant 2Thalidomide 2Prochlorperazine 2Electroacupuncture 2Dronabinol 2Analgesia 2Acupressure 2sinomenine 1netupitant 1lerisetron 1dolasetron 1dexamethasone acetate 1Tropisetron 1Therapeutics 1Taxes 1Tablets 1Surveys and Questionnaires 1Sugars 1Metoclopramide 1Hygiene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Vomiting × ramosetron × Clear all
NCT02011659 2013-12-13

PONV

National Health Insurance Service Ilsan Hospital

Phase 3 Unknown
128 enrolled
Gynecologic

Ovarian Neoplasms, Vomiting, Postoperative Nausea and Vomiting, Myofibroma, Adenomyosis

NCT01536691 2012-10-03

ROAD

Hallym University Medical Center

Phase 3 Unknown
338 enrolled

Neoplasms, Vomiting

NCT00971399 2011-02-28

Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting

Seoul National University Hospital

Phase 3 Completed
172 enrolled

Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡